Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 crore
Swiss drugmaker Novartis AG has agreed to sell its entire 70.68% stake in its Indian unit for Rs…
Novartis to exit listed Indian arm in Rs 1,446cr deal
New Delhi: Swiss drug firm Novartis will sell its entire stake of nearly 71% in its listed Indian…
ChrysCapital, two others launch open offer for Novartis India
Mumbai: A consortium of WaveRise Investments, ChrysCapital and Two Infinity Partners have announced an open offer to acquire…
Novartis to exit Indian unit in $159 million deal
Feb 20 (Reuters) – Swiss drugmaker Novartis said on Friday it would sell its entire 70.68% stake in…
Novartis Sells Majority Stake in Indian Arm to ChrysCapital
In a significant reshaping of its Indian operations, Swiss drug giant Novartis has announced an agreement to…
ChrysCapital inks $159 mn control deal for Novartis India, makes open offer
The Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann Homegrown private equity firm ChrysCapital…
Novartis to sell majority stake in India unit in ₹1,446 crore deal | Company News
The stake will be acquired by a consortium of WaveRise Investments, ChrysCapital and Two Infinity Partners (Photo: Reuters)…
Novartis AG to sell entire 70.68% stake for ₹1,445.89 crore in India unit; stock jumps 18%
Novartis India share price surged 18% in intra-day trade on Friday, February 20, after promoter Novartis AG agreed…